Company profiles

Print
 Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Sanofi Genzyme
500 Kendall Street,
Cambridge, MA 02142
USA
VP Media Relations
Contact person: Erin Pascal
 Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families. Learn more at www.sanofigenzyme.com
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis Group companies employ approximately 122,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world.
ACADIA Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. Headquartered in San Diego, the company has more than 400 employees.

Acorda Therapeutics
420 Saw Mill River Road
Ardsley, New York 10502
Telephone: 914-347-4300
Email: info@acorda.com,
Website: www.acorda.com
Founded in 1995, Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda has a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson’s disease and multiple sclerosis. Acorda markets two FDA-approved therapies, including AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg. Please visit www.acorda.com, our Facebook and LinkedIn pages, and follow @acordanews on Twitter to learn more. We also sponsor The Many Faces of OFF Facebook page; visit here.
At Adamas, we seek to redefine the treatment experience for patients suffering from chronic neurological diseases. Our treatment innovations stem from a deep scientific understanding of time-dependent biology – the deliberate mapping of disease patterns and drug activity – along with a goal to meaningfully increase the efficacy of known molecules without compromising tolerability. This approach is designed to ensure that our medicines fit within, rather than define, people’s daily lives.
Boston Scientific (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical devices with approximately 27,000 employees and revenue of $8.4 billion in 2016.
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.eu and connect on Twitter (@bostonsci) and Facebook.
Lundbeck N.A.
Six Parkway North
Deerfield, IL 60015
Telephone: 847-282-1000
Fax: 847-282-1001
Lundbeck, a global pharmaceutical company based in Denmark and founded in 1915, strives for global leadership in psychiatry and neurology by improving the lives of patients. One of the world’s leading companies specializing in brain disorders, Lundbeck is focused on innovating treatments for depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.
Teva is among the top 15 global pharmaceutical companies, delivering high-quality, patient-centric healthcare solutions used by approximately 200 million patients in 60 markets every day. Diseases of the central nervous system represent a key therapeutic area for Teva, with the company producing a world leading multiple sclerosis (MS) therapy. In neurology, Teva is dedicated to providing treatments for migraine and headache, movement disorders, neurodegenerative conditions and pain, and has late-stage development programs in a number of these neurological conditions. In Europe, Teva operates a number of research & development facilities, production and distribution centres, with the company’s European headquarters based in Amsterdam, the Netherlands


At US WorldMeds our mission is to market meaningful products that improve lives and result in a thriving community of patients. We hold a fundamental belief that our science has the potential to improve the lives of Parkinson’s patients. US WorldMeds’ commitment to Parkinson’s patients is reflected in all that we do. Our pipeline of development projects, along with our two currently available PD treatments, reflects our resolve to bring innovative solutions to Parkinson’s patients.

Britannia Pharmaceuticals, part of the STADA Arzneimittel AG group of companies, is a UK based pharmaceutical company. We specialise in innovative products for chronic and serious medical conditions, and in particular, the treatment of Parkinson’s disease. We are highly committed to improving the quality of life for People with Parkinson's disease

Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. For more information, please visit www.biogen.com.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ need using the latest technologies to develop and deliver innovative biotherapies that are used to treat serious and rare conditions such as coagulation disorders, primary immune deficiencies, hereditary angioedema and inherited respiratory disease.


UNIPHARM HOLDINGS Sp. z o. o.
ul. Puławska 428, 02-884 Warszawa
Telephone: 22 855 00 66-67
Fax: 22 643 81 60
NIP 9512441769; REGON: 367822108
Website: www.unipharm.pl
Email: info@unipharm.pl

UNIPHARM is an American pharmaceutical company headquartered in Empire State Building in New York with 15 branch offices worldwide. For over 25 years the Company has specialized in the development and marketing of over-the-counter drugs and nutritional products. UNIPHARM brands are leaders in the categories focused on patients and physicians needs in prevention and treatment of lifestyle diseases. UNIPHARM provides innovative solutions inter alia in neurology, rheumatology, orthopedy, endocrinology, ophthalmology.

UNIPHARM is first to market with unique nutraceutical AXOBREX, which provides inner salt of citicoline, a new neuroplastic and neuroprotective opportunity in therapeutic area of neurology and ophthalmology.

A clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases by selectively targeting shared critical pathways that are the root cause of disease. Led by a team of global leaders in inflammation and autoimmunity, Viela Bio strives to be a fully integrated biotechnology company, helping millions of patients worldwide. We are defined by our core competencies including deep therapeutic knowledge and operational effectiveness.



Website: www.abbvie.com
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. Follow @abbvie on Twitter, Facebook or LinkedIn.

Biofarm Sp. z o.o. in Poznań is one of the largest manufacturers of pharmaceuticals in Poland. We have been enjoying a dynamic growth since 1988 when the company was officially launched. Biofarm’s consistent growth of its market position is due to the high quality of its products and the continuous efforts to expand its product portfolio. Since the introduction of the first drug in 1992, Biofarm has provided approximately 140 million packages of various drugs to patients. The company was ranked 19th among 500 global pharmaceutical manufacturers which operate in the Polish market, and 3rd among pharmaceutical companies with the sole Polish capital. As early as 2001 and as one of the first pharmaceutical companies on the Polish market, Biofarm was granted the GMP (Good Manufacturing Practice) certificate that confirms meeting the highest standards of pharmaceutical manufacture quality. Biofarm has over 500 employees who form a carefully selected team of active and involved people.

CeGaT GmbH
Paul-Ehrlich-Str. 23
72076 Tuebingen, Germany
Email: info@cegat.de
Website: www.cegat.de
CeGaT is a leading global provider of genetic diagnostics and mutation-related disease analyses. The company combines its next-generation sequencing (NGS) process and analysis pipelines with its medical expertise - dedicated to identifying the genetic cause of disease and supporting patient management.
Genetic mutations can trigger a wide range of diseases, from epilepsy to Parkinson’s. Through the use of NGS, it is possible to analyze all genes associated with a disease phenotype simultaneously – both fast and effectively. An interdisciplinary team of scientists and human geneticists evaluates the data and summarizes the findings in a comprehensive medical report. All services are performed in-house. CeGaT, founded in 2009 and based in Tübingen, Germany, is accredited according to CAP, CLIA and DIN EN ISO 15189:2014. The company provides human genetics services worldwide.
Edra Urban & Partner Sp. z o.o.
ul. Kościuszki 29; 50-011 Wrocław,
Telephone: (+48 71) 330 61 89
Fax: (+48 71)330 61 60
Edra Urban & Partner, the new Polish reality in healthcare and part of Edra LSWR, the leading Italian provider of innovative solutions for the health system, acquires publishing activities of Elsevier Urban & Partner, the most authoritative and recognized medical publisher in Poland. Over twenty years of experience and a catalog boasting more than 800 titles have made Elsevier Urban & Partner the first point of reference for students and professionals in Poland.
Edra Urban & Partner intends to create comprehensive offers for the Polish health and medical environment, which will result in customers having access to more diverse and richer content with innovative products and services.



Roche Polska Sp. z o.o.
ul. Domaniewska 39B
02-672 Warszawa
NIP: 522-00-14-461
Roche Polska is a leading provider of innovative healthcare solutions. Roche has been helping physicians in Poland in their daily struggle for the health and well-being of patients for more than one hundred years. Company also work with academic and medical associations.
Roche shares the view that the key areas influencing Poland’s development, innovation and science are particularly important, which is why we have been engaged in R&D activities for many years, making both areas a key element of our corporate social responsibility. Poland plays also an important role in the Roche product development strategy, participating in the majority of its international clinical trials.
We are a pharmaceutical company based in Elizówka near Lublin. We operate in the market since 2005. Thanks to our long experience and dynamic development we are one of the fastest growing companies in the pharmaceutical industry in the Lubelskie province.
We create unique solutions for keeping good health, offering a vast choice of: foods for special medical purposes, medical devices, medicinal products, dietary supplements, cosmetic products.
We do our best to adjust not only to the changing requirements of the market, but also to the customers’ expectations. While constantly incorporating new products into our offer, we rely on researching the patients’ needs, as well as on the opinions of people from the medical community. We won the doctors’, pharmacists’ and patients’ trust, for we use the latest production technologies, as well as pay utmost attention to providing the best quality.

The company's history goes back to 1933 – date of establishment and start of industrial pharmaceutical production in Bulgaria, as a joint cooperative effort of the Union of Bulgarian Pharmacists. In 1942 from a small-scale production laboratory it becomes first modern pharmaceutical factory on the Balkans (Galenus Pharma). After privatization in 2000 – Sopharma becomes a privately held pharmaceutical company. In subsequent years the new state-of-the-art solid-forms factory of Sopharma is operational and won three awards in the construction sector. In 2007 The Bulgarian Rose Sevtopolis and Medica AD join Sopharma Group. And now Sopharma is a leading Bulgarian pharmaceutical manufacturer of branded and generic pharmaceuticals. Sopharma’s OTC and prescription drugs are well accepted in more than 20 markets due to their quality, efficiency and reasonable pricing. We are a respected contract manufacturer catering to markets like Europe, Asia, Africa, and North America (the largest share in its export markets is realized in Russia, Ukraine and Poland). More than 180 different products are produced by Sopharma’s pharmaceutical manufacturing plants and distributed to 25+ countries for various international partners. The tablet plant has an advanced manufacturing capacity, a plentitude of technological experience and a committed and highly qualified team. We are capable of manufacturing a large variety of tablet shapes and sizes. Upon demand, customised tablet shapes can also be manufactured. Tablets can be coated according to customers’ needs, using film or sugar coatings. The capability of our organization and its facilities capacity is a quarantee for a high quality affordable product in a timely manner. We are a company with more than 80 years’ tradition and a modern approach for production of human medicines, meeting EU quality standards, and corporate social responsibility. We manufacture products up to the highest quality standards. Sopharma is a holder of EU GMP - certified manufacturing sites for different dosage forms with the assurance for high product quality.
SpektrumCannabis is an international company that provides safe and consistent medical cannabis products and unbiased education for healthcare professionals. The Spectrum, our straightforward colour-coding categorization system based on cannabinoid content, simplifies product selection.
SpektrumCannabis allows patients and prescribing healthcare professionals to speak the same language and maintain consistent terminology, ensuring effective communication during the product selection process.



Wisepress Medical Bookshop
25 High Path, Merton Abbey,
London, SW19 2JL UK
Telephone: +44 20 8715 1812
Fax: +44 20 8715 1722
Email: marketing@wisepress.com,
Website: www.wisepress.com
Wisepress.com, Europe's leading conference bookseller, has a range of books and journals relevant to the themes of the meeting. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers. Follow us on Twitter for the latest news @WisepressBooks.

POLISH STROKE SOCIETY has been established in 2002 in Bydgoszcz to hold and support activities for the stroke therapy, prevention and education. As an interdisciplinary scientific society, it gathers almost 300 specialists, including neurologists, cardiologist, neurosurgeons and rehabilitation specialists, focused on stroke therapy, prevention and rehabilitation. Annually, POLISH STROKE SOCIETY organises interdisciplinary stroke meetings or congress dedicated to specific stroke aspects. In the wide field of activities, POLISH STROKE SOCIETY cooperates with Polish Society for Emergency Medicine, Section of Neurosonology of Polish Neurological Society, Danube Teaching Courses and numerous Polish and international experts.